Indian Scientists Develop Breakthrough Gene Therapy For Haemophilia A

Indian scientists at CMC Vellore developed the first human gene therapy using lentiviral vectors for severe haemophilia A. The therapy showed transformational results in a clinical trial, eliminating annual bleeding episodes in all five participants. This breakthrough offers hope for patients with haemophilia A, potentially transforming treatment for the condition, with further trials planned.